Similar to most cancers, GC has a molecular genetic basis that depends on the abnormalities in normal cellular regulatory mechanisms that govern cell proliferation.26 In this study, we measured CDKL2 expression in GC and analyzed the relationship between CDKL2 expression and different clinical and pathological characteristics. The gene discussed is CDKL2; the disease is cancer.